The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
Research suggests booster doses may be necessary for monkeypox immunity ... In contrast, for previously vaccinated individuals, the median titer 28 days after a single dose of the MVA-BN vaccine ...
After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. Jynneos, the only FDA-approved mpox ...
Mpox, formally known as Monkeypox, cases are on the rise, CDC says. Mpox, formerly known as monkeypox, cases are on the rise here in the U.S., with nearly double the number of infections compared ...
Labcorp (LH) receives FDA emergency use authorization for its Mpox PCR Test Home Collection Kit, which can detect the ...
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...
, opens new tab diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug ...